Hannah Cohen

15.9k total citations · 3 hit papers
195 papers, 9.4k citations indexed

About

Hannah Cohen is a scholar working on Hematology, Rheumatology and Internal Medicine. According to data from OpenAlex, Hannah Cohen has authored 195 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hematology, 74 papers in Rheumatology and 35 papers in Internal Medicine. Recurrent topics in Hannah Cohen's work include Systemic Lupus Erythematosus Research (73 papers), Platelet Disorders and Treatments (43 papers) and Blood Coagulation and Thrombosis Mechanisms (38 papers). Hannah Cohen is often cited by papers focused on Systemic Lupus Erythematosus Research (73 papers), Platelet Disorders and Treatments (43 papers) and Blood Coagulation and Thrombosis Mechanisms (38 papers). Hannah Cohen collaborates with scholars based in United Kingdom, United States and Italy. Hannah Cohen's co-authors include Raj Rai, Samuel J. Machin, Ian Mackie, L. Regan, Manisha Dave, Barbara Panning, Douglas Yasumura, Kevan M. Shokat, Han Li and Chao Zhang and has published in prestigious journals such as Science, Blood and PLoS ONE.

In The Last Decade

Hannah Cohen

190 papers receiving 9.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response

2007 1.1k citations Jonathan H. Lin, Han Li et al. Science profile →
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

1997 728 citations Hannah Cohen et al. profile →
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial

2016 278 citations Hannah Cohen, Maria Efthymiou et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hannah Cohen	3.7k	2.7k	1.7k	1.3k	1.3k	195	9.4k
Philippe de Moerloose	3.2k 0.9×	1.3k 0.5×	697 0.4×	1.2k 1.0×	1.0k 0.8×	220	8.2k
Samuel J. Machin	4.4k 1.2×	1.6k 0.6×	3.1k 1.8×	1.4k 1.1×	1.1k 0.9×	205	9.5k
George M. Rodgers	2.6k 0.7×	941 0.3×	1.1k 0.6×	1.0k 0.8×	915 0.7×	187	7.2k
Klaus Lechner	10.8k 2.9×	2.3k 0.8×	4.9k 2.8×	1.8k 1.4×	1.7k 1.3×	453	18.8k
Frank W.G. Leebeek	6.1k 1.6×	467 0.2×	963 0.6×	2.1k 1.6×	2.4k 1.9×	392	12.3k
Véronique Regnault	2.2k 0.6×	662 0.2×	463 0.3×	1.8k 1.4×	794 0.6×	128	5.9k
Amiram Eldor	4.0k 1.1×	417 0.2×	945 0.5×	2.8k 2.2×	1.7k 1.4×	226	11.1k
Christine Mannhalter	4.6k 1.2×	835 0.3×	1.6k 0.9×	1.9k 1.4×	929 0.7×	338	10.9k
Joan Carles Reverter	2.1k 0.6×	1.5k 0.5×	835 0.5×	1.0k 0.8×	950 0.8×	222	6.3k
Bonno N. Bouma	5.8k 1.5×	693 0.3×	923 0.5×	1.2k 0.9×	796 0.6×	188	9.1k

Countries citing papers authored by Hannah Cohen

Since Specialization

Citations

This map shows the geographic impact of Hannah Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Cohen more than expected).

Fields of papers citing papers by Hannah Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Cohen. The network helps show where Hannah Cohen may publish in the future.

Co-authorship network of co-authors of Hannah Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Cohen. A scholar is included among the top collaborators of Hannah Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Cohen. Hannah Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaspar, Pedro, et al.. (2025). Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy. Lupus. 34(4). 405–411. 1 indexed citations

Kerner, Nancy, Terry E. Goldberg, Hannah Cohen, et al.. (2024). Sleep–wake behavior, perceived fatigability, and cognitive reserve in older adults. Alzheimer s & Dementia. 20(6). 4020–4031. 3 indexed citations

Cohen, Hannah, et al.. (2024). Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study. Lupus. 33(10). 1082–1088. 1 indexed citations

Efthymiou, Maria, María Laura Bertolaccini, & Hannah Cohen. (2024). Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome. Lara D. Veeken. 63(SI). SI54–SI63. 1 indexed citations

Chighizola, Cecilia Beatrice, Francesca Pregnolato, Danieli Andrade, et al.. (2023). Fluctuation of Anti–Domain 1 and Anti–β₂‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis & Rheumatology. 75(6). 984–995. 12 indexed citations

Hostettler, Isabel C., David Seiffge, Andrew Wong, et al.. (2022). APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage. Neurology. 99(12). e1290–e1298. 8 indexed citations

Hostettler, Isabel C., Ghil Schwarz, Gareth Ambler, et al.. (2021). Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage. Neurology. 96(15). e1954–e1965. 14 indexed citations

Efthymiou, Maria, et al.. (2021). Coexistent antiphospholipid syndrome and myeloproliferative neoplasm. Lupus. 30(9). 1502–1508. 2 indexed citations

Cohen, Hannah & David Isenberg. (2020). How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome. Blood. 137(3). 299–309. 18 indexed citations

10.

Banerjee, Gargi, Duncan Wilson, Gareth Ambler, et al.. (2020). Longer term stroke risk in intracerebral haemorrhage survivors. Journal of Neurology Neurosurgery & Psychiatry. 91(8). 840–845. 14 indexed citations

11.

Cohen, Hannah, María J. Cuadrado, Doruk Erkan, et al.. (2020). 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus. 29(12). 1571–1593. 85 indexed citations

12.

Cohen, Hannah, Maria Efthymiou, & Katrien Devreese. (2020). Monitoring of anticoagulation in thrombotic antiphospholipid syndrome. Journal of Thrombosis and Haemostasis. 19(4). 892–908. 26 indexed citations

13.

Wilson, Duncan, Gareth Ambler, Clare Shakeshaft, et al.. (2019). Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA. BMJ Open. 9(7). e028387–e028387. 2 indexed citations

14.

Cohen, Hannah, et al.. (2013). RAPS: a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. UCL Discovery (University College London). 1 indexed citations

15.

Jones, Hayley E, Edwin Massey, Nay Win, et al.. (2011). Erratum: Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma (Transfusion (2009) 49 (440-452)). UCL Discovery (University College London). 1 indexed citations

16.

Lin, Jonathan H., Han Li, Douglas Yasumura, et al.. (2007). IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response. Science. 318(5852). 944–949. 1140 indexed citations breakdown →

17.

Gardiner, Clare, et al.. (2005). Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. UCL Discovery (University College London). 4 indexed citations

18.

Gibson, Brenda, Audrey Todd, Irene Roberts, et al.. (2004). Transfusion guidelines for neonates and older children. British Journal of Haematology. 124(4). 433–453. 229 indexed citations

19.

Williamson, Lorna M., Hannah Cohen, Elizabeth M. Love, et al.. (2000). The Serious Hazards of Transfusion (SHOT) Initiative: The UK Approach to Haemovigilance. Vox Sanguinis. 78(S2). 291–295. 48 indexed citations

20.

Cohen, Hannah, et al.. (1988). A COMPARISON OF THE EFFECTS OF 2 TRIPHASIC ORAL-CONTRACEPTIVES ON HEMOSTASIS. UCL Discovery (University College London).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact